Growth Metrics

Cardlytics (CDLX) Return on Equity (2017 - 2025)

Cardlytics' Return on Equity history spans 9 years, with the latest figure at 18.46% for Q4 2025.

  • For Q4 2025, Return on Equity rose 2117.0% year-over-year to 18.46%; the TTM value through Dec 2025 reached 18.46%, up 2117.0%, while the annual FY2025 figure was 3.26%, 141.0% down from the prior year.
  • Return on Equity reached 18.46% in Q4 2025 per CDLX's latest filing, up from 4.1% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 18.46% in Q4 2025 to a low of 4.1% in Q3 2025.
  • Average Return on Equity over 5 years is 0.32%, with a median of 0.89% recorded in 2024.
  • The largest YoY upside for Return on Equity was 2117bps in 2025 against a maximum downside of -224bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.19% in 2021, then crashed by -530bps to 1.17% in 2022, then skyrocketed by 36bps to 0.75% in 2023, then tumbled by -262bps to 2.71% in 2024, then surged by 781bps to 18.46% in 2025.
  • Per Business Quant, the three most recent readings for CDLX's Return on Equity are 18.46% (Q4 2025), 4.1% (Q3 2025), and 2.99% (Q2 2025).